SCHEMBL4174013

SCHEMBL4174013

CCOc1ccc(/C=C(\C(N)=O)S(=O)(=O)Cc2ccc(Cl)cc2)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR2 P21452 1/20 0.47
▸ MAPT P10636 6/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ MITF O75030 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ UBE2N P61088 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ LMNA P02545 3/20 0.45
▸ HTT P42858 3/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ ALDH1A1 P00352 6/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ TRPM5 Q9NZQ8 1/20 0.44
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4174018 1.00 TACR2 (0.47) TACR2MAPTNPC1RAB9AMITF
SCHEMBL4174021 1.00 TACR2 (0.47) TACR2MAPTNPC1RAB9AMITF
SCHEMBL4182838 0.90 PTPN7 (0.46) MAPTNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL4182828 0.90 PTPN7 (0.46) MAPTNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL4182835 0.90 PTPN7 (0.46) MAPTNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL4177534 0.87 MAPT (0.58) MAPTNPC1RAB9AMITFPOLB
SCHEMBL4181326 0.87 LMNA (0.42) MAPTNPC1RAB9APOLBKMT2A
SCHEMBL4177545 0.87 MAPT (0.58) MAPTNPC1RAB9AMITFPOLB
SCHEMBL4181331 0.87 LMNA (0.42) MAPTNPC1RAB9APOLBKMT2A
SCHEMBL4181334 0.87 LMNA (0.42) MAPTNPC1RAB9APOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 TACR2 4301/4885MAPT 3633/4885NPC1 4546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback